| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $6,511,067 ) |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21CA301519 | MDS-associated U2AF1 mutations induce natural killer cell dysfunction | 000 | 1 | NIH | 4/2/2026 | $435,062 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01DA057266 | Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy | 001 | 3 | NIH | 2/6/2026 | $52,628 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01DA057266 | Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy | 000 | 3 | NIH | 1/30/2026 | $473,648 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI182277 | Mast Cell Lineage Commitment and Function | 000 | 2 | NIH | 12/1/2025 | $614,256 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI189915 | Prenatal programming of immune cells for tissue repair and remodeling in asthma | 000 | 1 | NIH | 2/19/2026 | $776,394 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AG073317 | Loss of progenitor function accelerates lung aging | 000 | 4 | NIH | 2/27/2026 | $685,103 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K01DK134835 | Transcriptional control of T cell function during type 1 diabetes | 000 | 3 | NIH | 12/22/2025 | $114,626 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL155894 | Interstitial macrophages in cigarette smoke-induced small airway remodeling | 000 | 5 | NIH | 2/16/2026 | $158,328 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08ES034820 | Transcriptional Responses to Wildfire Pollution in Airway Epithelial Cells Identify Genetic Risk Factors and Mechanisms of Asthma Exacerbations | 000 | 4 | NIH | 1/15/2026 | $165,888 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI152037 | ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | 001 | 7 | NIH | 4/17/2026 | $330,358 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35HL161238 | Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | 000 | 5 | NIH | 2/3/2026 | $946,200 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM141603 | Innate Immune signal transduction specificity in inflammatory disease | 003 | 6 | NIH | 2/16/2026 | $250,000 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM141603 | Innate Immune signal transduction specificity in inflammatory disease | 002 | 6 | NIH | 2/9/2026 | $165,000 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R21AI196335 | Uncovering the role of resident memory T cell in chronic lung disease viral infections | 000 | 1 | NIH | 2/4/2026 | $470,219 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01ES033678 | Using Multi-Omics to Define Regulators and Drivers of Granulomatous Inflammation and Chronic Beryllium Disease | 000 | 5 | NIH | 12/30/2025 | $556,630 |
| | 2026 | 2026 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173030 | Activation of matrix metalloproteinase-9 is essential to overcome failed fibrosis resolution | 000 | 3 | NIH | 3/25/2026 | $665,180 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM141603 | Innate Immune signal transduction specificity in inflammatory disease | 004 | 5 | NIH | 2/16/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL155325 | Contribution of pulmonary ionocytes and neuroendocrine cells to ion transport-mediated airway surface liquid maintenance | 000 | 5 | NIH | 2/12/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 000 | 13 | NIH | 12/3/2025 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 000 | 5 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI151021 | Transcriptional Control of T Cell Function | 000 | 5 | NIH | 2/10/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 04 | 2 | HRSA | 3/13/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 03 | 2 | HRSA | 11/21/2025 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H1G53351 | Radiation Exposure Screening and Education Program | 02 | 2 | HRSA | 11/13/2025 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01AI152037 | ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | 000 | 6 | NIH | 3/26/2026 | $0 |
| | 2026 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R35GM141603 | Innate Immune signal transduction specificity in inflammatory disease | 001 | 5 | NIH | 1/14/2026 | $237,651 |
| | 2026 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL122995 | Asthma susceptibility due to environmental programming of innate immunity in utero | 000 | 10 | NIH | 2/6/2026 | $0 |
| | 2026 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL077328 | Ceramide-Induced Destruction in Emphysema | 000 | 19 | NIH | 12/8/2025 | $0 |
| | 2026 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI143837 | Maternal programming of the stem cell-basophil axis for asthma | 000 | 4 | NIH | 12/18/2025 | -$5,603 |
| | 2026 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI156901 | The Origin and Role of Pulmonary ILC2 Subsets in Anti-Helminth Immunity | 000 | 5 | NIH | 1/30/2026 | -$2,836 |
| | 2026 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | H3700066 | BLACK LUNG | 03 | 22 | HRSA | 4/1/2026 | -$473,204 |
| | 2026 | 2024 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UM1AI151958 | ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | 000 | 5 | NIH | 4/15/2026 | $0 |
| | 2026 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL148437 | Development and Validation of a Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis | 000 | 4 | NIH | 12/1/2025 | $0 |
| | 2026 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL147860 | Reducing Fibroblast Persistence in Pulmonary Fibrosis as a Mechanism of Resolution | 000 | 5 | NIH | 2/18/2026 | -$3,134 |
| | 2026 | 2023 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01ES029430 | Optimization of AEOL10150 treatment of sulfur mustard-induced lung toxidrome in a pig model | 000 | 5 | NIH | 12/17/2025 | -$92,692 |
| | 2026 | 2022 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | U01HL138689 | An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation | 000 | 6 | NIH | 12/30/2025 | -$1 |
| | 2026 | 2021 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | UH3TR002445 | Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis | 000 | 4 | NIH | 1/7/2026 | -$8,635 |
|
| Issue Date FY: 2025 ( Subtotal = $24,357,774 ) (Continued on the next page) |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL155325 | Contribution of pulmonary ionocytes and neuroendocrine cells to ion transport-mediated airway surface liquid maintenance | 000 | 5 | NIH | 4/9/2025 | $429,742 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI165922 | DNA induction of neutrophilic asthma | 000 | 5 | NIH | 8/27/2025 | $511,805 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL144727 | Mechanisms of right ventricle adaptation to pulmonary hypertension | 002 | 6 | NIH | 8/27/2025 | $726,487 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL141264 | Role of FABP5 in COPD Exacerbations | 001 | 6 | NIH | 7/1/2025 | $591,985 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL155894 | Interstitial macrophages in cigarette smoke-induced small airway remodeling | 000 | 4 | NIH | 12/23/2024 | $158,328 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL173239 | Integrative Metabolomics of Sarcoidosis Diagnosis and Progression | 000 | 1 | NIH | 4/1/2025 | $760,374 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K01DK134835 | Transcriptional control of T cell function during type 1 diabetes | 000 | 2 | NIH | 12/11/2024 | $114,626 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI182277 | Mast Cell Lineage Commitment and Function | 000 | 1 | NIH | 12/2/2024 | $612,328 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | K08HL171850 | Bcl-2 dependent fibroblast resistance to apoptosis occurs through persistent IL-6 signaling | 001 | 2 | NIH | 7/2/2025 | $156,816 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01HL168278 | Reparative functions of human airspace macrophage subsets | 000 | 2 | NIH | 7/11/2025 | $602,955 |
| | 2025 | 2025 | NATIONAL JEWISH HEALTH | 1400 JACKSON ST | DENVER | CO | 80206-2761 | DENVER | USA | R01AI155749 | MDS-Associated Spliceosome Mutations Regulate Host Defense | 000 | 5 | NIH | 2/28/2025 | $523,165 |
|
